PROPANC BIOPHARMA, INC. (PPCB) Free cash flow 2019–2026
PROPANC BIOPHARMA, INC. (PPCB) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$5.7MFY2026 · since FY2019: -$2.1M → -$5.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$5.7M | — |
| FY2019 | -$2.1M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More PPCB financial trends
PPCB RevenuePPCB Net incomePPCB Net marginPPCB Gross profitPPCB Gross marginPPCB Operating incomePPCB Operating marginPPCB Operating cash flowPPCB Capital expendituresPPCB Return on equityPPCB Stock buybacksPPCB Dividends paidPPCB Total assetsPPCB Total liabilitiesPPCB Shareholders’ equityPPCB overview →